Back
Business
-
Briefly
CHENNAI: Ranbaxy Laboratories and Merck & Co of the U.S. have signed an agreement for drug discovery and clinical development collaboration for new products in the anti-infective field. The collaboration will begin this year with an initial term of five years and can be extended mutually thereafter by the parties, says a release. © Copyright 2000 - 2009 The Hindu |